FDA board votes to approve gene therapy for Duchenne muscular dystrophy

Gene therapy for Duchenne muscular dystrophy gets FDA approval

FDA approves first gene therapy for muscular dystrophy

Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy

FDA Approves First Gene Therapy for Duchenne Muscular Dystrophy

Gene Therapy for Duchenne Muscular Dystrophy: Cash’s Story

MDA Engage: Gene Therapy and Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy: Could Gene Therapy Be the Answer? Exploring SRP-9001

Arkansas Children’s Patient is First in State to Receive FDA-Approved DMD Gene Therapy

Two Olympia boys have Duchenne muscular dystrophy, but only one is eligible for a new treatment

5-year-old receives 'historic' gene therapy treatment

FDA approves new gene therapy for muscular dystrophy patients

Cure Rare Disease has received FDA Approval for its first Duchenne muscular dystrophy therapeutic

In the Pipeline: Restoring Dystrophin - Sarepta Therapeutics (RNA Targeted Therapies)

CHKD patient the first in state to receive new gene therapy treatment

FDA Approves First Gene Therapy for Muscular Dystrophy: A Major Step Forward

Sarepta Announces FDA Approval of ELEVIDYS

Sarepta Soars on Expanded Approval for Muscular Dystrophy Drug

DMD Gene Therapy Clinical Trials

DMD and Gene Therapy What's On the Horizon